Table 1.
Patient characteristics
| Parameters | n = 208 |
|---|---|
| Median age when receiving HSCT, y (range) | 30 (4–57) |
| Gender | |
| Male | 124 (60%) |
| Female | 84 (40%) |
| c-KIT gene at diagnosis | |
| Mutation | 69 (33%) |
| Wild type | 80 (39%) |
| Unknown | 59 (28%) |
| First CR induction courses | |
| 1 | 136 (65%) |
| >1 | 58 (28%) |
| Unknown | 14 (7%) |
| Interval between diagnosis and HSCT | |
| <8 months | 110 (53%) |
| ≥8 months | 98 (47%) |
| Disease status when receiving HSCT | |
| First CR | 179 (86%) |
| Second CR | 29 (14%) |
| Donor source | |
| HLA-matched sibling | 60 (29%) |
| Haploidentical | 135 (65%) |
| Unrelated donor | 10 (5.5%) |
| Cord blood | 1 (0.5%) |
| Conditioning regimen | |
| Chemotherapy based | 204 (98.1%) |
| TBI based | 4 (1.9%) |